BeiGene Statistics

Total Valuation

BeiGene has a market cap or net worth of HKD 188.39 billion. The enterprise value is 175.44 billion.

Market Cap	188.39B
Enterprise Value	175.44B

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.07%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	64.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	7.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-26.43
EV / Sales	6.72
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-18.95

Financial Position

The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.31.

Current Ratio	1.94
Quick Ratio	1.64
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-0.88
Interest Coverage	-57.74

Financial Efficiency

Return on equity (ROE) is -23.22% and return on invested capital (ROIC) is -12.29%.

Return on Equity (ROE)	-23.22%
Return on Assets (ROA)	-9.58%
Return on Invested Capital (ROIC)	-12.29%
Return on Capital Employed (ROCE)	-23.29%
Revenue Per Employee	2.46M
Profits Per Employee	-626,262
Employee Count	10,600
Asset Turnover	0.58
Inventory Turnover	1.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.40% in the last 52 weeks. The beta is 0.63, so BeiGene's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+46.40%
50-Day Moving Average	116.04
200-Day Moving Average	109.33
Relative Strength Index (RSI)	78.43
Average Volume (20 Days)	1,599,502

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.34

Income Statement

In the last 12 months, BeiGene had revenue of HKD 26.04 billion and -6.64 billion in losses. Loss per share was -63.61.

Revenue	26.04B
Gross Profit	21.79B
Operating Income	-6.89B
Pretax Income	-6.23B
Net Income	-6.64B
EBITDA	-6.18B
EBIT	-6.89B
Loss Per Share	-63.61

Full Income Statement

Balance Sheet

The company has 21.09 billion in cash and 8.18 billion in debt, giving a net cash position of 12.91 billion.

Cash & Cash Equivalents	21.09B
Total Debt	8.18B
Net Cash	12.91B
Net Cash Per Share	n/a
Equity (Book Value)	26.77B
Book Value Per Share	251.12
Working Capital	14.71B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.05 billion and capital expenditures -4.21 billion, giving a free cash flow of -9.26 billion.

Operating Cash Flow	-5.05B
Capital Expenditures	-4.21B
Free Cash Flow	-9.26B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 83.67%, with operating and profit margins of -26.45% and -25.50%.

Gross Margin	83.67%
Operating Margin	-26.45%
Pretax Margin	-23.91%
Profit Margin	-25.50%
EBITDA Margin	-23.72%
EBIT Margin	-26.45%
FCF Margin	n/a

Dividends & Yields

BeiGene does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.07%
Shareholder Yield	0.07%
Earnings Yield	-3.52%
FCF Yield	-4.91%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BeiGene has an Altman Z-Score of 2.96. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.96
Piotroski F-Score	n/a